calendar
300 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 3,921 phase readout · 2,141 8k filing · 2,000 device pma
300 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 3,921 phase readout · 2,141 8k filing · 2,000 device pma
Anticipated earnings call for CSL LTD ($CSLLY).
Anticipated earnings call for Beyond Air, Inc. ($XAIR).
Anticipated earnings call for Haleon plc ($HLN).
Anticipated earnings call for SMITH & NEPHEW PLC ($SNN).
Anticipated earnings call for Scilex Holding Co ($SCLX).
Anticipated earnings call for BioXcel Therapeutics, Inc. ($BTAI).
Anticipated earnings call for ACME UNITED CORP ($ACU).
Therapy area: Dermatology. Indication: Vitiligo
Anticipated earnings call for Grifols SA ($GRFS).
Anticipated earnings call for Sanofi ($SNY).
Therapy area: Gastrointestinal. Indication: Anal Fissure, Hemorrhoids
Therapy area: Central Nervous System, Gastrointestinal. Indication: Inguinal Hernia, Post-Operative Pain
Therapy area: Immunology. Indication: Rheumatoid Arthritis
Therapy area: Immunology. Indication: Immunoglobulin G4-Related Disease (IgG4-RD)
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization, Dry (Atrophic) Macular Degeneration, Geographic Atrophy
Therapy area: Immunology. Indication: Rheumatoid Arthritis
Therapy area: Cardiovascular, Dermatology. Indication: Melasma (Chlosma), Venous Thromboembolism
Therapy area: Respiratory. Indication: Obstructive Sleep Apnea
Therapy area: Genito Urinary System, Non Malignant Disorders. Indication: Burning Sensation, Oral Submucosal Fibrosis
Anticipated earnings call for NOVARTIS AG ($NVS).
Anticipated earnings call for INCYTE CORP ($INCY).
Anticipated earnings call for ECOLAB INC. ($ECL).
Anticipated earnings call for Orion Group Holdings Inc ($ORN).
Therapy area: Oncology. Indication: Head And Neck Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Hypopharyngeal Cancer, Laryngeal Cancer, Oral Cavity (Mouth) Cancer, Oropharyngeal Cancer, Recurrent Head And Neck Squamous Cell Carcinoma
Therapy area: Oncology. Indication: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Therapy area: Respiratory. Indication: Seasonal Allergic Rhinitis
Therapy area: Ophthalmology. Indication: Open-Angle Glaucoma
Therapy area: Metabolic Disorders. Indication: Fabry Disease
Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes
Anticipated earnings call for AbbVie Inc. ($ABBV).
Anticipated earnings call for ASTRAZENECA PLC ($AZN).
Anticipated earnings call for GSK plc ($GSK).
Anticipated earnings call for REGENERON PHARMACEUTICALS, INC. ($REGN).
Anticipated earnings call for TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA).
Anticipated earnings call for GLAUKOS Corp ($GKOS).
Anticipated earnings call for BIOGEN INC. ($BIIB).
Anticipated earnings call for Bausch & Lomb Corp ($BLCO).
Anticipated earnings call for SBA COMMUNICATIONS CORP ($SBAC).
Anticipated earnings call for AGIOS PHARMACEUTICALS, INC. ($AGIO).
Anticipated earnings call for IONIS PHARMACEUTICALS INC ($IONS).
Anticipated earnings call for Avantor, Inc. ($AVTR).
Anticipated earnings call for MERIT MEDICAL SYSTEMS INC ($MMSI).
Anticipated earnings call for Merck & Co., Inc. ($MRK).
Anticipated earnings call for CARDINAL HEALTH INC ($CAH).
Anticipated earnings call for DEXCOM INC ($DXCM).
Anticipated earnings call for ELI LILLY & Co ($LLY).
Anticipated earnings call for STRYKER CORP ($SYK).
Anticipated earnings call for BRISTOL MYERS SQUIBB CO ($BMY).
Anticipated earnings call for AMGEN INC ($AMGN).
Anticipated earnings call for BIOMARIN PHARMACEUTICAL INC ($BMRN).